Skip to main content
. 2017 Dec 19;11:358. doi: 10.3389/fncel.2017.00358

Figure 7.

Figure 7

EMAP-II combined with anti-miR-330-3p and PKCα activator enhance the effects of DOX on inhibiting the cell viabilities and promoting the apoptosis of U87 glioma cells. (A) The cell viabilities of U87 glioma cells were assessed by MTT. (B) Apoptosis analysis inU87 glioma cells was evaluated by Annexin V-PE/7-AAD staining. Values are means ± SD (n = 5, each). *P < 0.05, **P < 0.01 vs. control group; #P < 0.05 vs. DOX group.